These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors. Nordberg GF, Jin T, Wu X, Lu J, Chen L, Lei L, Hong F, Nordberg M. Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860 [Abstract] [Full Text] [Related]
3. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China. Chen L, Jin T, Huang B, Nordberg G, Nordberg M. Toxicol Appl Pharmacol; 2006 Aug 15; 215(1):93-9. PubMed ID: 16510161 [Abstract] [Full Text] [Related]
5. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers]. Chen L, Jin TY, Chang XL, Lei LJ, Zhou YF. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan 15; 24(1):7-11. PubMed ID: 16600085 [Abstract] [Full Text] [Related]
6. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China. Nordberg GF. Toxicol Lett; 2010 Jan 15; 192(1):45-9. PubMed ID: 19540908 [Abstract] [Full Text] [Related]
8. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China. Chen L, Jin T, Huang B, Chang X, Lei L, Nordberg GF, Nordberg M. Toxicol Sci; 2006 May 15; 91(1):104-12. PubMed ID: 16322080 [Abstract] [Full Text] [Related]
9. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure. Chang X, Jin T, Chen L, Nordberg M, Lei L. Exp Biol Med (Maywood); 2009 Jun 15; 234(6):666-72. PubMed ID: 19359654 [Abstract] [Full Text] [Related]
10. Metallothionein gene expression in peripheral lymphocytes and renal dysfunction in a population environmentally exposed to cadmium. Lu J, Jin T, Nordberg G, Nordberg M. Toxicol Appl Pharmacol; 2005 Aug 07; 206(2):150-6. PubMed ID: 15967203 [Abstract] [Full Text] [Related]
11. Increased hepatic and decreased urinary metallothionein in rats after cessation of oral cadmium exposure. Liang Y, Li H, Xiang C, Lei L, Jin T, Nordberg M, Nordberg GF. Basic Clin Pharmacol Toxicol; 2010 Apr 07; 106(4):348-55. PubMed ID: 20030629 [Abstract] [Full Text] [Related]
12. Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters. Lei LJ, Chen L, Jin TY, Nordberg M, Chang XL. Toxicol Sci; 2007 May 07; 97(1):189-95. PubMed ID: 17303580 [Abstract] [Full Text] [Related]
15. [Renal dysfunction in workers exposed to arsenic and cadmium]. Hong F, Jin TY, Lu GD, Yin ZY. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Dec 07; 21(6):432-6. PubMed ID: 14761355 [Abstract] [Full Text] [Related]
16. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein. Min KS, Onosaka S, Tanaka K. Toxicol Appl Pharmacol; 1996 Nov 07; 141(1):102-9. PubMed ID: 8917681 [Abstract] [Full Text] [Related]
17. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan. Kobayashi E, Suwazono Y, Uetani M, Inaba T, Oishi M, Kido T, Nishijo M, Nakagawa H, Nogawa K. Environ Res; 2006 Jul 07; 101(3):401-6. PubMed ID: 16436274 [Abstract] [Full Text] [Related]
19. [Calculation of the combined renal dysfunction risk in patients co-exposed to arsenicum and cadmium by using benchmark dose method]. Hong F, Jin TY, Zhang AH. Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov 07; 38(6):374-8. PubMed ID: 15569507 [Abstract] [Full Text] [Related]
20. [Application of metallothionein gene isoforms expression as biomarkers in cadmium exposure]. Chang XL, Jin TY, Chen L, Lei LJ, Zhou YF. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan 07; 24(1):12-5. PubMed ID: 16600086 [Abstract] [Full Text] [Related] Page: [Next] [New Search]